Notification Filed by a National Securities Exchange to Report the Removal From Listing and Registration of Matured , Redeemed or Retired Securities (25)

OMB APPROVAL
OMB Number:		3235-0058
Expires:		May 31, 2024
Estimated average burden
hours per response		1.00

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

FORM 25

 

 

NOTIFICATION OF REMOVAL FROM LISTING

AND/OR REGISTRATION UNDER SECTION 12(b)

OF THE SECURITIES EXCHANGE ACT OF 1934

Commission File Number: 001-40414

 

 

Skylight Health Group Inc., The Nasdaq Stock Market LLC

(Exact name of Issuer as specified in its charter, and name of Exchange

where security is listed and/or registered)

 

 

5520 Explorer Drive, Suite 402,

Mississauga, Ontario L4W 5L1;

Tel: [phone]

(Address, including zip code, and telephone number, including area code, of Issuer’s principal executive offices)

Common Shares, no par value, and 9.25% Series A Cumulative Redeemable Perpetual Preferred Shares, no par value per share

(Description of class of securities)

 

 

Please place an X in the box to designate the rule provision relied upon to strike the class of securities from listing and registration:

 

☐	17 CFR 240.12d2-2(a)(1)

 

☐	17 CFR 240.12d2-2(a)(2)

 

☐	17 CFR 240.12d2-2(a)(3)

 

☐	17 CFR 240.12d2-2(a)(4)

 

☐	Pursuant to 17 CFR 240.12d2-2(b), the Exchange has complied with its rules to strike the class of securities from listing and/or withdraw registration on the Exchange.1

 

☒	Pursuant to 17 CFR 240.12d2-2(c), the Issuer has complied with the rules of the Exchange and the requirements of 17 CFR 240.12d2-2(c) governing the voluntary withdrawal of the class of securities from listing and registration on the Exchange.

Pursuant to the requirements of the Securities Exchange Act of 1934, Skylight Health Group Inc. (Name of Issuer or Exchange) certifies that it has reasonable grounds to believe that it meets all of the requirements for filing the Form 25 and has caused this notification to be signed on its behalf by the undersigned duly authorized person.

 

August 15, 2022				By		Pradyum Sekar				Chief Executive Officer
Date						Name				Title

 

1	Form 25 and attached Notice will be considered compliance with the provisions of 17 CFR 240.19d-1 as applicable. See General Instructions.

 

SEC 1654 (03-06)		Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.